Our Services
Medical Information
Helpful Resources
Published on: 11/9/2026
Walking pneumonia, usually caused by Mycoplasma pneumoniae, and acute bronchitis can look nearly identical, with a lingering dry cough, low-grade fever, and chest tightness, yet bronchitis is typically viral while walking pneumonia involves infection deeper in the lung tissue. The distinction matters because macrolide antibiotics like azithromycin have historically been the first-line treatment for atypical pneumonia, but rising macrolide resistance means some people fail to improve after 48 to 72 hours and need a different drug class or further imaging. Subtle or "atypical" chest findings, such as scattered crackles, wheezing, or a clear exam despite abnormal X-ray patches, make bedside diagnosis unreliable without testing. Several factors influence which condition you have and whether antibiotics will help at all, including age, symptom duration, exposure history, and local resistance patterns, so see below to understand more before assuming a cough is harmless.
Because a persistent cough with chest discomfort can mean anything from a self-limiting viral illness to a bacterial infection that resists standard antibiotics, taking a free, instant, online symptom check can help you organize your symptoms, flag warning signs like shortness of breath or fever beyond a week, and decide whether you need same-day care, a chest X-ray, or simply rest and time.
Last reviewed for medical accuracy: 11/09/2026
A persistent cough, tiredness, chest discomfort, or a low-grade fever can occur with both walking pneumonia and acute bronchitis. The two illnesses may feel similar, especially early on, but they are not the same. Walking pneumonia is a form of pneumonia that can cause infection and inflammation in the lung tissue. Acute bronchitis usually affects the larger airways and is most often caused by a virus.
The distinction matters because pneumonia may require antibiotics and closer medical follow-up, while antibiotics usually do not help uncomplicated acute bronchitis. Diagnosis can be more difficult when the chest examination sounds mild or unusual and when the bacteria causing walking pneumonia are resistant to commonly used antibiotics called macrolides.
“Walking pneumonia” is a common name for a relatively mild form of pneumonia. It does not mean the infection is harmless. Rather, people with walking pneumonia may remain able to walk around and perform some daily activities instead of becoming severely ill or needing hospitalization.
One frequent cause is Mycoplasma pneumoniae, a bacterium that spreads through respiratory droplets. Other bacteria and viruses can also cause pneumonia with relatively mild symptoms.
Common symptoms include:
A person with walking pneumonia may not have the classic signs associated with severe pneumonia, such as a high fever, rapid breathing, or obvious difficulty breathing. However, symptoms can worsen, and older adults, young children, pregnant people, and those with chronic heart, lung, or immune conditions may be at greater risk of complications.
Acute bronchitis is inflammation of the breathing tubes, or bronchi. It commonly follows a cold or another viral respiratory infection. The cough can be troublesome and may produce clear, white, yellow, or green mucus. Mucus color alone does not prove that a bacterial infection is present.
Acute bronchitis commonly causes:
According to guidance from the Centers for Disease Control and Prevention and other medical organizations, routine antibiotics are not recommended for uncomplicated acute bronchitis. Antibiotics do not treat viruses and can cause side effects or contribute to antibiotic resistance.
Pneumonia does not always produce dramatic findings when a clinician listens to the lungs. A person may have pneumonia even if there are no obvious crackles, wheezes, or areas of reduced breath sounds. Conversely, bronchitis can cause noisy breathing, wheezing, or chest tightness without pneumonia being present.
This is one reason clinicians consider the entire picture rather than relying on one symptom. They may assess:
A chest X-ray may be needed when pneumonia is suspected, particularly if there is a high or persistent fever, rapid breathing, low oxygen, significant shortness of breath, confusion, or abnormal lung findings. A chest X-ray cannot always identify the exact cause, but it can help show whether pneumonia is likely.
Macrolides are a group of antibiotics that includes azithromycin and clarithromycin. They have historically been used for some “atypical” pneumonia infections, including infections caused by Mycoplasma pneumoniae.
The problem is that macrolide-resistant Mycoplasma pneumoniae has been identified in many parts of the world. Resistance rates vary by region and over time. When the bacteria are resistant, a macrolide may not work well, even when the diagnosis is correct.
This creates several challenges:
Macrolide resistance does not mean that walking pneumonia is untreatable. It means that the best antibiotic cannot be chosen by habit alone. Clinicians may consider other options, such as doxycycline for appropriate adults, or another medicine when clinically suitable. Some alternatives are not appropriate for children or pregnancy, so treatment should be selected by a qualified healthcare professional.
People should not stop, switch, or restart antibiotics without speaking with a doctor. It is also important not to use leftover medication or someone else’s prescription.
| Feature | Walking pneumonia | Acute bronchitis |
|---|---|---|
| Usual cause | Bacteria such as Mycoplasma, or sometimes viruses | Usually a virus |
| Main problem | Infection and inflammation in lung tissue | Inflammation of the larger airways |
| Fever | May occur, sometimes gradually | Usually absent or mild |
| Cough | Often persistent and dry or mildly productive | Common and may produce mucus |
| Breathing symptoms | Shortness of breath may occur | Wheezing or chest tightness may occur |
| Chest examination | May be subtle or inconsistent | May be normal or show wheezing |
| Chest X-ray | May show pneumonia | Usually does not show pneumonia |
| Antibiotics | May be needed if bacterial pneumonia is diagnosed | Usually not helpful |
This table is a general guide, not a way to diagnose yourself. Viral infections, asthma, COVID-19, influenza, pertussis, pulmonary embolism, and other conditions can resemble bronchitis or pneumonia.
Speak to a doctor if a cough is severe, lasts longer than expected, keeps returning, or is accompanied by fever, shortness of breath, chest pain, dehydration, or unusual fatigue. Medical advice is especially important for infants, older adults, pregnant people, and anyone with a weakened immune system or chronic heart or lung disease.
You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to organize your symptoms and decide what type of care may be appropriate. An online checker cannot confirm pneumonia, determine antibiotic resistance, or replace an examination.
Seek urgent medical care for:
These symptoms can signal a serious or life-threatening problem. Speak to a doctor immediately about anything that could be life-threatening or serious.
Walking pneumonia and acute bronchitis can share many symptoms, but pneumonia involves the lung tissue and may require antibiotic treatment. Acute bronchitis is usually viral and generally improves with rest, fluids, and symptom care rather than antibiotics.
Atypical symptoms or mild lung findings do not rule out pneumonia. At the same time, a persistent cough does not automatically mean that antibiotics are needed. Macrolide-resistant bacteria make treatment decisions more complicated, so a clinician may need to combine the examination, symptom pattern, local resistance information, and sometimes chest imaging before choosing treatment.
(References)
* Cheong KN, Chiu SS, Chan BW, To KK, Chan EL, Ho PL. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure. J Microbiol Immunol Infect. 2016 Feb;49(1):127-30. doi: 10.1016/j.jmii.2014.11.003. Epub 2014 Nov 11. PMID: 25556047.
* Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017 Jul;30(3):747-809. doi: 10.1128/CMR.00114-16. PMID: 28539503; PMCID: PMC5475226.
* Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018 Jan;16(1):23-34. doi: 10.1080/14787210.2018.1414599. Epub 2017 Dec 11. PMID: 29212389.
* Nakamura Y, Oishi T, Kaneko K, Kenri T, Tanaka T, Wakabayashi S, Kono M, Ono S, Kato A, Kondo E, Tanaka Y, Teranishi H, Akaike H, Miyata I, Ogita S, Ohno N, Nakano T, Ouchi K. Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children. J Infect Chemother. 2021 Feb;27(2):271-276. doi: 10.1016/j.jiac.2020.10.007. Epub 2020 Oct 21. PMID: 33500118.
* Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Jul 1;5(7):e2220949. doi: 10.1001/jamanetworkopen.2022.20949. Epub 2022 Jul 1. PMID: 35816304; PMCID: PMC9274321.
* Wu TH, Fang YP, Liu FC, Pan HH, Yang YY, Song CS, Lee CY. Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017-2023. Emerg Infect Dis. 2024 Aug;30(8):1692-1696. doi: 10.3201/eid3008.231596. PMID: 39043456; PMCID: PMC11286047.
* Wang YS, Zhou YL, Bai GN, Li SX, Xu D, Chen LN, Chen X, Dong XY, Fu HM, Fu Z, Hao CL, Hong JG, Liu EM, Liu HM, Lu XX, Luo ZX, Tang LF, Tian M, Yin Y, Zhang XB, Zhang JH, Zhang HL, Zhao DY, Zhao SY, Zhu GH, Zou YX, Lu Q, Zhang YY, Chen ZM. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. World J Pediatr. 2024 Sep;20(9):901-914. doi: 10.1007/s12519-024-00831-0. Epub 2024 Aug 14. PMID: 39143259; PMCID: PMC11422262.
* Wang Y, Xue C, Luo Q, Ma J, Zeng X. Detection of Mycoplasma pneumoniae Nucleic Acid and Drug Resistance Gene. J Vis Exp. 2025 Sep 19;(223). doi: 10.3791/68500. Epub 2025 Sep 19. PMID: 41051998.
* Yun KW. Growing Threat of Macrolide-Resistant Mycoplasma pneumoniae Among Children: What We Know and What We Need. J Korean Med Sci. 2025 Nov 10;40(43):e317. doi: 10.3346/jkms.2025.40.e317. Epub 2025 Nov 10. PMID: 41218593; PMCID: PMC12602143.
* Miyashita N, Ogata M, Fukuda N, Yamura A, Ito T. Clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia: Can the JRS pneumonia guidelines be applied? Respir Investig. 2026 Jul;64(4):101454. doi: 10.1016/j.resinv.2026.101454. Epub 2026 Jun 2. PMID: 42224951.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.